Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis

J Lubke; J Schwaab; N Naumann; HP Horny; C Weiss; G Metzgeroth; S Kreil; NCP Cross; Karl Sotlar; A Fabarius; WK Hofmann; P Valent; J Gotlib; M Jawhar; A Reiter

doi:10.1200/JCO.21.01849

Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis

J Lubke
, J Schwaab
, N Naumann
, HP Horny
, C Weiss
, G Metzgeroth
, S Kreil
, NCP Cross
, Karl Sotlar (Co-author)
, A Fabarius
, WK Hofmann
, P Valent
, J Gotlib
, M Jawhar
, A Reiter

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

32 Citations (Web of Science)

Original language	English
Pages (from-to)	1783-+
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	40
Issue number	16
DOIs	https://doi.org/10.1200/JCO.21.01849
Publication status	Published - 2022

Keywords

MAST-CELL DISEASE
KIT D816V
PROGNOSTIC IMPACT
CONTROLLED-TRIALS
ADULT PATIENTS
WORK-UP
DIAGNOSIS
CLASSIFICATION
SAFETY
RISK

Access to Document

10.1200/JCO.21.01849

Cite this

Lubke, J., Schwaab, J., Naumann, N., Horny, HP., Weiss, C., Metzgeroth, G., Kreil, S., Cross, NCP., Sotlar, K., Fabarius, A., Hofmann, WK., Valent, P., Gotlib, J., Jawhar, M., & Reiter, A. (2022). Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis. JOURNAL OF CLINICAL ONCOLOGY , 40(16), 1783-+. https://doi.org/10.1200/JCO.21.01849

Lubke, J ; Schwaab, J ; Naumann, N et al. / Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis. In: JOURNAL OF CLINICAL ONCOLOGY 2022 ; Vol. 40, No. 16. pp. 1783-+.

@article{c1b3856f16e842d1b6fff315b9171d4e,

title = "Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis",

keywords = "MAST-CELL DISEASE, KIT D816V, PROGNOSTIC IMPACT, CONTROLLED-TRIALS, ADULT PATIENTS, WORK-UP, DIAGNOSIS, CLASSIFICATION, SAFETY, RISK",

author = "J Lubke and J Schwaab and N Naumann and HP Horny and C Weiss and G Metzgeroth and S Kreil and NCP Cross and Karl Sotlar and A Fabarius and WK Hofmann and P Valent and J Gotlib and M Jawhar and A Reiter",

note = "[Sotlar, Karl] Department of Pathology, Paracelsus Medical University of Salzburg, Salzburg, Austria",

year = "2022",

doi = "10.1200/JCO.21.01849",

language = "English",

volume = "40",

pages = "1783--+",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins ",

number = "16",

}

Lubke, J, Schwaab, J, Naumann, N, Horny, HP, Weiss, C, Metzgeroth, G, Kreil, S, Cross, NCP, Sotlar, K, Fabarius, A, Hofmann, WK, Valent, P, Gotlib, J, Jawhar, M & Reiter, A 2022, 'Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis', JOURNAL OF CLINICAL ONCOLOGY , vol. 40, no. 16, pp. 1783-+. https://doi.org/10.1200/JCO.21.01849

Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis. / Lubke, J; Schwaab, J; Naumann, N et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 40, No. 16, 2022, p. 1783-+.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis

AU - Lubke, J

AU - Schwaab, J

AU - Naumann, N

AU - Horny, HP

AU - Weiss, C

AU - Metzgeroth, G

AU - Kreil, S

AU - Cross, NCP

AU - Sotlar, Karl

AU - Fabarius, A

AU - Hofmann, WK

AU - Valent, P

AU - Gotlib, J

AU - Jawhar, M

AU - Reiter, A

N1 - [Sotlar, Karl] Department of Pathology, Paracelsus Medical University of Salzburg, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - MAST-CELL DISEASE

KW - KIT D816V

KW - PROGNOSTIC IMPACT

KW - CONTROLLED-TRIALS

KW - ADULT PATIENTS

KW - WORK-UP

KW - DIAGNOSIS

KW - CLASSIFICATION

KW - SAFETY

KW - RISK

U2 - 10.1200/JCO.21.01849

DO - 10.1200/JCO.21.01849

M3 - Original Article

C2 - 35235417

SN - 0732-183X

VL - 40

SP - 1783-+

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 16

ER -

Lubke J, Schwaab J, Naumann N, Horny HP, Weiss C, Metzgeroth G et al. Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis. JOURNAL OF CLINICAL ONCOLOGY . 2022;40(16):1783-+. doi: 10.1200/JCO.21.01849